INBRAIN Neuroelectronics announces world’s first human graphene-based Brain Computer Interface procedure
INBRAIN Neuroelectronics has announced the world’s first human procedure of its cortical interface in a patient undergoing brain tumor resection. INBRAIN’s BCI technology was able to differentiate between healthy and cancerous brain tissue with micrometer-scale precision.
This milestone represents an advancement in demonstrating the ability of graphene-based BCI technology beyond decoding and translating brain signals, to become a reliable tool for use in precision surgery in diseases such as cancer, and in neurotechnology more broadly. The study was sponsored by the University of Manchester, and primarily funded by the European Commission’s Graphene Flagship project. The clinical investigation study was conducted at Salford Royal Hospital.